Login / Signup

Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.

James F HowardSaskia BreschConstantine FarmakidisMiriam FreimerAngela GengeChanna HewamaddumaJohn HintonYessar HussainRaul Juntas-MoralesHenry J KaminskiAngelina ManiaolRenato MantegazzaMasayuki MasudaRichard J NowakKumaraswamy SivakumarMarek ŚmiłowskiKimiaki UtsugisawaTuan VuMichael D WeissMałgorzata ZajdaJos BloemersBabak BoroojerdiMelissa BrockGuillemette de la BorderiePetra W DudaMark VanderkelenM Isabel Leitenull null
Published in: Therapeutic advances in neurological disorders (2024)
ClinicalTrials.gov identifier: NCT04225871 (https://clinicaltrials.gov/ct2/show/NCT04225871).
Keyphrases
  • myasthenia gravis
  • open label
  • clinical trial
  • computed tomography
  • image quality
  • squamous cell carcinoma
  • dual energy
  • randomized controlled trial
  • phase ii
  • phase iii